Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Scalet

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Human Mutation|November 9, 2018
Disease-causing variants of the conserved +2T of 5' splice sites can be rescued by engineered U1snRNAsDaniela Scalet, Iva Maestri, Alessio Branchini, et al.
Molecular Therapy. Nucleic Acids|October 5, 2016
An Exon-Specific U1snRNA Induces a Robust Factor IX Activity in Mice Expressing Multiple Human FIX Splicing MutantsDario Balestra, Daniela Scalet, Franco Pagani, et al.
Human Molecular Genetics|June 12, 2015
Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotidesDario Balestra, Elena Barbon, Daniela Scalet, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 19, 2016
Exploring Splicing-Switching Molecules For Seckel Syndrome TherapyDaniela Scalet, Dario Balestra, Sara Rohban, et al.
Journal of Human Genetics|March 3, 2018
The somatic FAH C.1061C>A change counteracts the frequent FAH c.1062+5G>A mutation and permits U1snRNA-based splicing correctionDaniela Scalet, Claudia Sacchetto, Francesco Bernardi, et al.
International Journal of Molecular Sciences|April 5, 2020
A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type IDario Balestra, Daniela Scalet, Mattia Ferrarese, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Human Mutation|November 9, 2018
Disease-causing variants of the conserved +2T of 5' splice sites can be rescued by engineered U1snRNAsDaniela Scalet, Iva Maestri, Alessio Branchini, et al.
Molecular Therapy. Nucleic Acids|October 5, 2016
An Exon-Specific U1snRNA Induces a Robust Factor IX Activity in Mice Expressing Multiple Human FIX Splicing MutantsDario Balestra, Daniela Scalet, Franco Pagani, et al.
Human Molecular Genetics|June 12, 2015
Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotidesDario Balestra, Elena Barbon, Daniela Scalet, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 19, 2016
Exploring Splicing-Switching Molecules For Seckel Syndrome TherapyDaniela Scalet, Dario Balestra, Sara Rohban, et al.
Journal of Human Genetics|March 3, 2018
The somatic FAH C.1061C>A change counteracts the frequent FAH c.1062+5G>A mutation and permits U1snRNA-based splicing correctionDaniela Scalet, Claudia Sacchetto, Francesco Bernardi, et al.
International Journal of Molecular Sciences|April 5, 2020
A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type IDario Balestra, Daniela Scalet, Mattia Ferrarese, et al.
Pageof 1